Vertex Planning Partners, LLC Pfizer Inc Transaction History

Vertex Planning Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $5,069 - $6,584	194 Added 2.79%	7,140 $206 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $15,916 - $18,604	-496 Reduced 6.66%	6,946 $230 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $21,744 - $25,157	602 Added 8.8%	7,442 $273 Million
Q1 2023 May 16, 2023	SELL	$39.39 - $51.28 $186,038 - $242,195	-4,723 Reduced 40.85%	6,840 $279 Million
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $482,755 - $630,183	11,563 New	11,563 $592 Million

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Vertex Planning Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Vertex Planning Partners, LLC with notifications on news.